DENTSPLY SIRONA (NASDAQ:XRAY) Given New $38.00 Price Target at Barrington Research

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target trimmed by Barrington Research from $41.00 to $38.00 in a research report sent to investors on Friday, Benzinga reports. The brokerage currently has an outperform rating on the medical instruments supplier’s stock.

Other equities research analysts have also issued research reports about the stock. StockNews.com upgraded shares of DENTSPLY SIRONA from a hold rating to a buy rating in a research note on Friday, January 19th. Leerink Partnrs reaffirmed an outperform rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Robert W. Baird cut their price target on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a research note on Friday. Needham & Company LLC lowered their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating on the stock in a research note on Friday. Finally, Piper Sandler reiterated a neutral rating and set a $32.00 target price (down previously from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA currently has an average rating of Moderate Buy and an average target price of $36.90.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $28.29 on Friday. The firm has a market capitalization of $5.87 billion, a P/E ratio of -64.29, a price-to-earnings-growth ratio of 1.15 and a beta of 1.00. The company has a current ratio of 1.43, a quick ratio of 0.95 and a debt-to-equity ratio of 0.54. The business’s fifty day simple moving average is $32.13 and its 200 day simple moving average is $32.71. DENTSPLY SIRONA has a 12 month low of $26.27 and a 12 month high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.39 EPS. As a group, analysts anticipate that DENTSPLY SIRONA will post 2.05 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were paid a dividend of $0.16 per share. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 annualized dividend and a yield of 2.26%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -145.45%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of XRAY. Parkside Financial Bank & Trust increased its stake in DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 292 shares during the last quarter. Beach Investment Counsel Inc. PA boosted its stake in DENTSPLY SIRONA by 1.4% in the fourth quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock worth $787,000 after buying an additional 306 shares in the last quarter. Wahed Invest LLC boosted its stake in DENTSPLY SIRONA by 9.3% in the fourth quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock worth $128,000 after buying an additional 306 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its position in DENTSPLY SIRONA by 5.4% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier’s stock valued at $237,000 after acquiring an additional 359 shares during the last quarter. Finally, VisionPoint Advisory Group LLC raised its stake in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 395 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.